A novel de novo mutation in <i>ATP1A3</i> and childhood-onset schizophrenia


Creative Commons License

Smedemark-Margulies N., Brownstein C. A., Vargas S., Tembulkar S. K., Towne M. C., Shi J., ...Daha Fazla

COLD SPRING HARBOR MOLECULAR CASE STUDIES, sa.5, 2016 (ESCI) identifier identifier

Özet

We describe a child with onset of command auditory hallucinations and behavioral regression at 6 yr of age in the context of longer standing selective mutism, aggression, and mild motor delays. His genetic evaluation included chromosomal microarray analysis and whole-exome sequencing. Sequencing revealed a previously unreported heterozygous de novo mutation c.385G>A in ATP1A3, predicted to result in a p.V129M amino acid change. This gene codes for a neuron-specific isoform of the catalytic a-subunit of the ATP-dependent transmembrane sodium-potassium pump. Heterozygous mutations in this gene have been reported as causing both sporadic and inherited forms of alternating hemiplegia of childhood and rapid-onset dystonia parkinsonism. We discuss the literature on phenotypes associated with known variants in ATP1A3, examine past functional studies of the role of ATP1A3 in neuronal function, and describe a novel clinical presentation associated with mutation of this gene.